The Enterprise Value as of December 2025 (TTM) for Newron Pharmaceuticals S.p.A. (NWRN.SW) is 455.00M

According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 455.00M. This represents a change of 147.03% compared to the average of 184.19M of the last 4 quarters.

Newron Pharmaceuticals S.p.A. (NWRN.SW) Historical Enterprise Value (quarterly & annually)

How has NWRN.SW Enterprise Value performed in the past?

The mean historical Enterprise Value of Newron Pharmaceuticals S.p.A. over the last ten years is 132.05M. The current 455.00M Enterprise Value has changed 34.36% with respect to the historical average. Over the past ten years (40 quarters), NWRN.SW's Enterprise Value was at its highest in in the June 2015 quarter at 313.75M. The Enterprise Value was at its lowest in in the June 2006 quarter at 0.

Newron Pharmaceuticals S.p.A. (NWRN.SW) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Newron Pharmaceuticals S.p.A. (NWRN.SW) Average Enterprise Value

How has NWRN.SW Enterprise Value performed in the past?

The current Enterprise Value of Newron Pharmaceuticals S.p.A. (NWRN.SW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Newron Pharmaceuticals S.p.A. (NWRN.SW) Enterprise Value vs. Peers

How is NWRN.SW’s Enterprise Value compared to its peers?

Newron Pharmaceuticals S.p.A.’s Enterprise Value is greater than COLTENE Holding AG (348.86M), greater than DocMorris AG (450.65M), greater than IVF Hartmann Holding AG (240.06M), greater than Santhera Pharmaceuticals Holding AG (216.00M), greater than Molecular Partners AG (46.08M), greater than Relief Therapeutics Holding AG (27.13M), greater than Addex Therapeutics Ltd (6.30M), less than Basilea Pharmaceutica AG (623.63M), greater than EvoNext Holdings S.A. (-413950.00), greater than Ascom Holding AG (98.01M),

Build a custom stock screener for Newron Pharmaceuticals S.p.A. (NWRN.SW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Newron Pharmaceuticals S.p.A. (NWRN.SW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.